Clinical trials
Phase 1 Mesothelioma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Completed | 4 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| AbbVie | 1 |
| MacroGenics | 1 |
| Pfizer | 1 |
| Symphogen A/S | 1 |
| Thunder Bay Regional Health Research Institute | 1 |
| Turnstone Biologics, Corp. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma | 11 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Colorectal Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Melanoma | 4 |
| Ovarian Neoplasms | 4 |
| Carcinoma, Renal Cell | 3 |
| Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Cholangiocarcinoma | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.